EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Intermuscular Adipose Tissue in CKD

Mert Demirci iD, R Gulsah Dilaver iD, Baback Roshanravan, T Alp Ikizler iD, Jorge L Gamboa iD

Clinical Journal of the American Society of Nephrology · 2025-07 · 20 (7) · 1014-1027

DOI: 10.2215/cjn.0000000745 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 30.04.2025. Verfasst von Mert Demirci und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Muscle, Skeletal, Adipose Tissue. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, US Department of Veterans Affairs, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with CKD often experience loss of muscle mass, altered muscle function, and low physical functionality, all of which contribute to increased mortality and morbidity. Mitochondrial dysfunction emerges early in the progression of CKD and may play a central role in physical dysfunction. Factors such as uremia, systemic inflammation, oxidative stress, and inappropriate activation of the renin-angiotensin-aldosterone system may play a role on mitochondrial dysfunction. On the other hand, the accumulation of ectopic adipose tissue in skeletal muscle, also known as intermuscular adipose tissue (IMAT), is a newly recognized factor in muscle function and physical performance. IMAT is a marker of muscle quality, adversely affecting local muscle function, and is associated with insulin resistance and systemic inflammation, conditions commonly observed in CKD. Nevertheless, the exact composition of IMAT and its relationship with mitochondria and muscle energetics in CKD is not fully understood. Evaluating the relationship between IMAT accumulation and mitochondrial dysfunction in CKD may unveil potential interventions to improve physical function and the quality of life of patients with CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicMuscle, SkeletalAdipose TissueHumansMitochondria, Muscle

Stichwörter der Autor:innen

CKDESKDdialysislean body massmitochondria

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Division of Nephrology, Department of Medicine, University of California, Davis, Davis, California.
  • Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

ORCID-Profile: Mert Demirci, R Gulsah Dilaver, T Alp Ikizler, Jorge L Gamboa

Förderung

  • NIDDK NIH HHS
  • US Department of Veterans Affairs
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Demirci, M., Dilaver, R. G., Roshanravan, B., Ikizler, T. A., & Gamboa, J. L. (2025). Intermuscular Adipose Tissue in CKD. Clinical Journal of the American Society of Nephrology, 20(7), 1014-1027. https://doi.org/10.2215/cjn.0000000745

Vancouver

Demirci M, Dilaver RG, Roshanravan B, Ikizler TA, Gamboa JL. Intermuscular Adipose Tissue in CKD. Clinical Journal of the American Society of Nephrology. 2025;20(7):1014-1027. doi:10.2215/cjn.0000000745

BibTeX
@article{Demirci2025,
  author = {Demirci, Mert and Dilaver, R Gulsah and Roshanravan, Baback and Ikizler, T Alp and Gamboa, Jorge L},
  title = {Intermuscular Adipose Tissue in CKD},
  journal = {Clinical Journal of the American Society of Nephrology},
  year = {2025},
  volume = {20},
  number = {7},
  pages = {1014--1027},
  doi = {10.2215/cjn.0000000745}
}
Kostenlos starten →